Human trial
Spermidine primary study · PMID 35616942
100 older adults with subjective cognitive decline in a 12-month randomized trial.
Reported findings. No positive effect established on the stated primary outcome.
Nonresponse. The primary memory outcome did not improve significantly compared with placebo.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. The studied wheat-germ extract is not equivalent to commercial spermidine trihydrochloride solution. Mechanistic autophagy findings do not prove lifespan extension.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.